Lesson plan
1F-LSD
1F-LSD, also known as 1-(2-furoyl)-LSD or as SYN-L-005, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is thought to act as a prodrug of LSD. The drug interacts with serotonin receptors, including the serotonin 5-HT 2A receptor, and produces the head-twitch response in rodents, with about 3-fold lower potency than LSD. It hydrolyzes into LSD in rodents. 1F-LSD was patented in 2024 and was first described in the scientific literature in 2025. It has been encountered as a novel designer drug in Germany and Japan.
Article summary
1F-LSD, also known as 1-(2-furoyl)-LSD or as SYN-L-005, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is thought to act as a prodrug of LSD. The drug interacts with serotonin receptors, including the serotonin 5-HT 2A receptor, and produces the head-twitch response in rodents, with about 3-fold lower potency than LSD. It hydrolyzes into LSD in rodents. 1F-LSD was patented in 2024 and was first described in the scientific literature in 2025. It has been encountered as a novel designer drug in Germany and Japan.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.